Please assess the completion status of the following clinical trial:

Trial Title: Trabectome Versus Trabeculectomy With Mitomycin C in Patients With Open Angle Glaucoma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 40-85 years~2. Open angle glaucoma (including pseudo exfoliative glaucoma)~3. Open angles (≥ Shaffer grade II)~4. Inadequately controlled IOP requiring surgical intervention~5. Visually significant cataract~6. Willing to complete quality of life questionnaires~7. Capable of informed consent and available for at least 1 year follow-up~Exclusion Criteria:~1. Any form of angle closure glaucoma~2. Secondary open angle glaucomas~3. Absence of clear angle landmarks on gonioscopy~4. Other ocular disease that may affect assessments of visual acuity, visual field, or accurate tonometry~5. Previous angle surgery or filtering procedure~6. Steroid use within the preceding 3 months~7. Presence of significant co-morbidities

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Trabectome-IOL (Type: ACTIVE_COMPARATOR): Combined Trabectome and cataract extraction with intraocular lens insertion
- Trab-IOL (Type: ACTIVE_COMPARATOR): Combined Trabeculetomy with Mitomycin C and cataract extraction with intraocular lens insertion

Based on this trial design, predict the completion outcome and termination type (if applicable).